The Silent Side of Women’s Sexual Health

For decades, sexual medicine seemed to have a much larger vocabulary for men's concerns than women's.

Erectile dysfunction became a recognized medical condition. Medications were developed, advertised, discussed openly, and prescribed routinely.

Meanwhile, many women experiencing changes in sexual function were left asking:

“What about me?”

A woman may still love her partner and want intimacy but notice that her body does not respond the way it once did.

She may experience:

• Less genital sensation

• Difficulty becoming physically aroused

• Reduced lubrication

• Orgasms that feel weaker

• Difficulty reaching orgasm

• A disconnect between mental desire and physical response

• Changes following menopause, childbirth, medication use, illness, or hormonal shifts

For some women, intercourse may still be physically possible—but pleasure, sensation, or responsiveness feels noticeably different.

These experiences are real, and they deserve more than being dismissed as stress or something a woman should simply learn to live with.

One emerging option in women's sexual medicine is a category of compounded topical medications often marketed under names such as “Scream Cream.”

The name is memorable. The science behind it requires a little more explanation.

What Exactly Is Scream Cream?

First, there is an important distinction:

Scream Cream is not the name of one standardized FDA-approved medication.

It is a nickname commonly used for customized topical preparations made by compounding pharmacies for female sexual arousal concerns.

Compounding means that a licensed pharmacy prepares a medication in a specific strength, dosage form, or combination for an individual patient.

Depending on the prescription and pharmacy, formulations marketed as Scream Cream may contain one or several ingredients intended to influence blood flow or genital response.

These can include medications or ingredients such as:

• Sildenafil

• Tadalafil

• L-arginine

• Pentoxifylline

• Aminophylline

Some compounded sexual-health formulations may contain hormonal ingredients, although hormone treatment represents a separate clinical decision and should not automatically be considered part of every arousal cream.

Because there is no universal Scream Cream formula, two products carrying the same nickname may be pharmacologically very different.

That distinction matters for both patients and practitioners.

The FDA does not approve compounded drugs before they are dispensed and therefore does not independently verify their safety, effectiveness, or quality the way it does with an FDA-approved medication. Compounding can fulfill legitimate medical needs, but treatment should involve an appropriately licensed prescriber and qualified compounding pharmacy.

Understanding Female Arousal: It Is More Than Libido

One reason female sexual concerns are frequently misunderstood is that desire, arousal, lubrication, sensation, and orgasm are related—but they are not the same thing.

Desire

Desire is the mental or emotional interest in sexual activity.

You might think:

“I want to have sex.”

Arousal

Arousal refers partly to the body's physical response to sexual stimulation.

Blood flow increases to the genital tissue. The clitoris and surrounding structures become engorged—or fuller with blood—and sensitivity may increase.

Orgasm

Orgasm is a complex neurological and muscular response involving the brain, nerves, pelvic muscles, genital tissue, and emotional experience.

A woman can therefore experience desire without strong physical arousal.

She can experience physical arousal without orgasm.

She can also experience orgasm while still believing her overall sexual satisfaction has declined.

This is why women's sexual health rarely has a single universal solution.

Why Blood Flow Matters to Female Sexual Response

Although female sexuality involves psychological, hormonal, neurological, relational, and physical factors, genital blood flow plays an important physiological role.

The clitoris contains erectile tissue.

During sexual stimulation, blood vessels supplying the genital region dilate—or widen—allowing more blood to enter the tissues.

That contributes to:

• Clitoral engorgement

• Genital warmth

• Lubrication

• Increased sensitivity

• Physical readiness for sexual activity

One chemical involved in this process is nitric oxide.

Nitric oxide signals blood vessels to relax and widen.

This same basic signaling pathway is involved in male erections, although female sexual response is considerably more complex than simply increasing blood flow.

That similarity is one reason researchers began investigating whether medications traditionally used for erectile dysfunction might also influence female genital arousal.

Sildenafil: The Viagra Connection

Sildenafil, commonly known by the brand name Viagra, belongs to a class of medications known as PDE5 inhibitors.

PDE5 stands for phosphodiesterase type 5, an enzyme that helps regulate blood-vessel signaling.

You do not need to remember the chemistry to understand the basic idea.

Think of nitric oxide as sending a message:

“Relax this blood vessel and let more blood through.”

PDE5 helps turn that message off.

A PDE5 inhibitor such as sildenafil slows that shutdown process, allowing the blood-flow signal to remain active longer.

In men, this can facilitate an erection when sexual stimulation occurs.

Researchers have investigated whether targeting the same pathway locally in women could improve genital arousal while potentially reducing some of the whole-body effects associated with taking sildenafil orally.

What Does the Research on Topical Sildenafil Actually Show?

This is where it is important to separate promising science from marketing.

A 2024 phase 2b randomized, double-blind, placebo-controlled study evaluated topical sildenafil cream 3.6% in 200 healthy premenopausal women diagnosed with female sexual arousal disorder.

Participants received either sildenafil cream or placebo for 12 weeks.

Overall, the sildenafil group showed greater improvement in some measurements, but the trial did not demonstrate statistically significant differences between sildenafil and placebo for its primary endpoints across the entire study population.

However, researchers conducted an exploratory analysis of women whose primary diagnosis was female sexual arousal disorder, with or without decreased desire but without certain additional sexual dysfunction diagnoses.

In that subgroup, women receiving sildenafil cream experienced statistically significant improvement in measures of:

• Arousal sensation

• Sexual desire

• Some orgasm-related outcomes

• Sexual distress

• Interpersonal difficulties related to sexual function

Those findings are encouraging, but they are preliminary.

The trial's authors themselves described the results as preliminary efficacy, meaning more research is needed before topical sildenafil can be considered an established treatment for all women experiencing sexual dysfunction.

For practitioners, this distinction is particularly important.

The evidence supports continued investigation—not universal claims that topical sildenafil reliably produces stronger or faster orgasms in every patient.

What Do We Know About Safety?

The same clinical development program also evaluated the safety of topical sildenafil 3.6%.

Researchers specifically monitored both participants and their sexual partners over the 12-week treatment period.

One reason topical treatment is appealing is the possibility of delivering medication directly to genital tissue while reducing the amount circulating throughout the entire body.

That is important because systemic PDE5 inhibitors can produce adverse effects such as:

• Headache

• Flushing

• Nasal congestion

• Lightheadedness

• Blood-pressure changes

The topical sildenafil formulation studied in the clinical trial had a generally favorable local and systemic safety profile during the study, but that evidence applies to the specific 3.6% formulation tested.

It should not automatically be extended to every compounded product sold as Scream Cream because formulations can differ substantially.

Why Might a Woman's Sexual Response Change?

Before reaching for any treatment, it is worth asking a more important question:

Why has sexual function changed?

Arousal and orgasm problems can result from several overlapping causes.

Perimenopause and Menopause

Declining estrogen can change vaginal and vulvar tissue.

Some women experience:

• Dryness

• Burning

• Less elasticity

• Discomfort with intercourse

• Reduced genital blood flow

• Changes in sensitivity

These symptoms may be part of what clinicians call genitourinary syndrome of menopause, or GSM.

That term describes estrogen-related changes affecting the vagina, vulva, bladder, and urinary tract after menopause.

If GSM is the primary problem, simply increasing arousal may not address the underlying tissue changes.

Low Testosterone or Hormonal Changes

Women produce testosterone too—just in considerably smaller quantities than men.

Testosterone participates in sexual desire and arousal, although hormone levels alone do not explain every libido problem.

A comprehensive hormone evaluation may therefore be appropriate for some patients, particularly when sexual changes occur alongside other symptoms.

Medications

Several medications can influence libido or orgasm.

Antidepressants—particularly certain selective serotonin reuptake inhibitors (SSRIs)—are well known for causing sexual side effects in some patients.

Other medications may affect:

• Desire

• Lubrication

• Genital sensation

• Ability to reach orgasm

Medication-related sexual dysfunction deserves a clinical conversation rather than silent frustration.

Never discontinue a medication abruptly because of sexual side effects. A provider can help evaluate alternatives or adjustments when appropriate.

Pelvic Floor Changes

Pregnancy, childbirth, surgery, aging, pain conditions, and pelvic-floor dysfunction can alter sensation and sexual response.

Some women benefit from pelvic-floor physical therapy either alone or alongside other treatments.

Stress, Sleep and Mental Health

The brain is arguably the body's most important sexual organ.

Chronic stress, exhaustion, anxiety, depression, relationship concerns, body-image changes, trauma history, and poor sleep can all influence sexual response.

That does not mean sexual dysfunction is “all in your head.”

It means the brain and body cannot realistically be separated when discussing sexuality.

“I Want Sex, but My Body Isn't Responding”

This is one of the situations in which a localized arousal treatment may be worth discussing.

A woman may have emotional desire and a satisfying relationship but experience reduced genital responsiveness.

She may describe it as:

“I know I'm turned on mentally, but physically nothing happens.”

Or:

“I can still orgasm, but it takes much longer than it used to.”

Or:

“I just don't have the same sensation anymore.”

Those statements contain valuable clinical information.

Instead of simply labeling everything “low libido,” a practitioner can determine whether the primary concern appears related to:

• Desire

• Physical arousal

• Genital sensation

• Pain

• Lubrication

• Orgasm

• Hormones

• Medication effects

• Relationship or psychological factors

Treatment can then target the actual problem.

Can Scream Cream Help Women Reach Orgasm?

Possibly—but this deserves more careful language than many online advertisements use.

Increasing genital blood flow and sensitivity may make sexual stimulation feel more noticeable for some women.

Because arousal contributes to orgasm, improved physical responsiveness could also improve orgasmic experience in certain patients.

The 2024 topical sildenafil study found improvement in orgasm-domain scores within an exploratory subgroup, which supports continued research in this area.

But orgasm involves considerably more than circulation.

It requires coordinated activity involving:

• Sensory nerves

• The spinal cord

• The brain

• Pelvic muscles

• Hormonal environment

• Psychological arousal

• Adequate stimulation

• Comfort and absence of pain

For that reason, no topical medication should be marketed as an automatic orgasm button.

Think of it as a potential tool within a much larger sexual-health toolbox.

What About Menopause and Scream Cream?

Menopause deserves special consideration because sexual symptoms can involve several systems simultaneously.

For example, a menopausal woman might experience:

• Lower estrogen

• Vaginal dryness

• Pain with penetration

• Reduced genital sensitivity

• Poor sleep

• Hot flashes

• Reduced libido

Treating only blood flow may leave the other factors untouched.

Depending on the individual, a comprehensive menopause strategy might instead involve discussion of:

• Vaginal moisturizers and lubricants

• Local vaginal estrogen when appropriate

• Menopausal hormone therapy when clinically indicated

• Pelvic-floor therapy

• Medication review

• Sleep treatment

• Sexual counseling

• Other evidence-based sexual-health therapies

Some patients may still be candidates for a customized topical arousal medication, but it should fit into the larger clinical picture.

What About Combining Scream Cream With PT-141, Oxytocin or Hormones?

This is another area where marketing often moves faster than research.

You may see online clinics recommending combinations such as:

Scream Cream + PT-141

or

Scream Cream + oxytocin

or

Scream Cream + testosterone

The theory behind combination therapy can sound compelling because each treatment targets a different pathway.

However, there is not currently strong clinical evidence establishing these combinations as universally safer or more effective than individual treatment.

That does not mean a practitioner can never consider multiple therapies.

It means they should not be presented as a proven “ultimate libido stack.”

For practitioners, combination therapy requires individualized assessment of:

• Indication

• Medication interactions

• Contraindications

• Cardiovascular status

• Hormonal status

• Adverse effects

• Treatment response

For patients, the key message is simpler:

More ingredients do not automatically equal better sexual function.

How Is Compounded Scream Cream Used?

Because formulations vary, there is no single universal dose or application schedule that applies to every product called Scream Cream.

That is why instructions should come directly from the prescribing provider and dispensing pharmacy.

Depending on the formulation, a topical medication may be applied to external genital tissue before anticipated sexual activity.

Patients should follow their prescription carefully regarding:

• How much to apply

• Where to apply it

• How long before intimacy to use it

• Maximum frequency

• Whether excess medication should be removed

• Whether precautions are necessary to avoid transfer to a partner

Possible local effects can include warmth, tingling, redness, burning, or irritation.

If significant irritation, dizziness, cardiovascular symptoms, or another unexpected reaction occurs, the prescribing clinician should be contacted.

Compounded Does Not Mean the Same Thing as FDA-Approved

This point deserves its own section because it is frequently misunderstood.

An FDA-approved medication has undergone agency review for its:

• Safety

• Effectiveness

• Manufacturing quality

• Labeling

• Dosing

A compounded medication has not gone through that same approval process.

The FDA states clearly that compounded drugs can provide an important option when an approved product cannot meet a patient's medical needs, but the agency does not verify compounded medications' safety, effectiveness, or quality before they reach patients.

That is why reputable prescribing and pharmacy practices matter.

Patients should know exactly what ingredients are in their prescription rather than relying only on a catchy name like “Scream Cream.”

Women's Sexual Health Deserves a Better Conversation

Perhaps the most meaningful thing about the growing interest in Scream Cream is not the cream itself.

It is the conversation surrounding it.

Women are increasingly saying:

Sexual satisfaction matters to my health.

And healthcare is finally beginning to listen.

Changes in arousal, sensation, orgasm, comfort, and desire are legitimate health concerns.

They can affect:

• Confidence

• Relationships

• Emotional wellbeing

• Body image

• Intimacy

• Quality of life

The answer does not need to be embarrassment, dismissal, or “that's just what happens when you get older.”

Sometimes there is a hormonal component.

Sometimes there is a vascular component.

Sometimes a medication is responsible.

Sometimes pain is interfering.

Sometimes the solution involves several approaches.

Finding the cause is more useful than assuming every woman needs the same treatment.

The Steel City HRT & Weight Loss Perspective

At Steel City HRT & Weight Loss, women's sexual health is treated as part of whole-person healthcare—not as an embarrassing afterthought.

If sexual function has changed, the goal is first to understand what changed and why.

That may include discussing:

• Menopause symptoms

• Hormone status

• Medications

• Sexual desire

• Physical arousal

• Genital sensitivity

• Vaginal comfort

• Difficulty reaching orgasm

• Sleep and stress

• Overall metabolic and cardiovascular health

When medically appropriate, a compounded topical arousal medication may be one option within an individualized treatment plan.

It is not a magic orgasm cream.

It is not appropriate for every woman.

And the science surrounding many compounded formulations is still developing.

But emerging evidence involving topical sildenafil gives practitioners another reason to take female arousal disorders seriously—and gives women something they should have had all along:

More options and a better conversation.

The Bottom Line: Your Pleasure Is Part of Your Health

Women's sexual function can change during perimenopause, menopause, after childbirth, during medication treatment, and throughout different stages of life.

That does not mean those changes must simply be ignored.

Topical sildenafil and compounded products commonly referred to as Scream Cream represent an emerging area of female sexual medicine.

Early research is encouraging for selected women with female sexual arousal disorder, but more study is needed, and compounded formulations should not be confused with the specific investigational sildenafil cream evaluated in clinical trials.

The bigger message is simple:

Women deserve evidence-based solutions for sexual health just as much as men do.

If your desire is present but your body no longer responds the way it used to—or if changes in sensitivity, arousal, comfort, or orgasm are affecting your quality of life—there may be more than one treatment option worth discussing.

Ready to Talk About Sexual Health Without the Awkwardness?

At Steel City HRT & Weight Loss, Jeremiah provides individualized care for women navigating hormonal changes, sexual-health concerns, menopause, and overall wellness.

A consultation can help determine whether changes in arousal or orgasm may be connected to hormones, medications, menopause, physical health, or another factor—and whether a compounded treatment or another approach may be appropriate.

Call Steel City HRT & Weight Loss at 719-669-4223 or visit SteelCity-trt.com to schedule a consultation.

Your sexual health matters.

And you deserve a healthcare conversation that treats it that way.

References

Johnson, I., Thurman, A. R., Cornell, K. A., Hatheway, J., Dart, C., Brainard, C. P., Friend, D. R., & Goldstein, A. (2024). Preliminary efficacy of topical sildenafil cream for the treatment of female sexual arousal disorder: A randomized controlled trial. Obstetrics & Gynecology, 144(2), 144–152. https://doi.org/10.1097/AOG.0000000000005648

Thurman, A. R., Johnson, I., Cornell, K. A., Hatheway, J., Kim, N. N., Parish, S. J., Dart, C., Friend, D. R., & Goldstein, A. (2024). Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder. The Journal of Sexual Medicine, 21(9), 793–799. https://doi.org/10.1093/jsxmed/qdae089

Johnson, I., Thurman, A. R., Cornell, K. A., et al. (2024). Impact of age, race, and medication use on efficacy endpoints in a randomized controlled trial of topical sildenafil cream for the treatment of female sexual arousal disorder. Sexual Medicine, 12(5), qfae079. https://doi.org/10.1093/sexmed/qfae079

U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.

U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs.